Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Research conducted at University of Texas has provided new information about breast cancer
May 28th, 2009
In this recently published article, scientists in the United States conducted a study "To examine the androgen receptor (AR) levels in breast cancer and to assess the impact of AIR expression on patient outcomes. Reverse-phase protein arrays were used to measure AR levels and a mass spectroscopy-based approach was used to detect PIK3CA mutations." "Means and SDs were generated for AR levels. Linear regression models were used to determine if AIR levels differed by tumor subtype and PIK3CA mutation status. Two-sample t tests were used to identify pair-wise differences. Survival probabilities were estimated with the use of the Kaplan-Meier product and log-rank test. The...
Source: Women's Health Weekly (2009-05-28)
|
